Projects per year
Abstract
Self-assembling virus-like particles represent highly attractive tools for developing next-generation vaccines and protein therapeutics. We created ADDomer, an adenovirus-derived multimeric protein-based self-assembling nanoparticle scaffold engineered to facilitate plug-and-play display of multiple immunogenic epitopes from pathogens. We used cryo–electron microscopy at near-atomic resolution and implemented novel, cost-effective, high-performance cloud computing to reveal architectural features in unprecedented detail. We analyzed ADDomer interaction with components of the immune system and developed a promising first-in-kind ADDomer-based vaccine candidate to combat emerging Chikungunya infectious disease, exemplifying the potential of our approach.
Original language | English |
---|---|
Article number | eaaw2853 |
Number of pages | 9 |
Journal | Science Advances |
Volume | 5 |
Issue number | 9 |
DOIs | |
Publication status | Published - 25 Sept 2019 |
Research Groups and Themes
- Bristol BioDesign Institute
- BrisSynBio
Keywords
- SYNTHETIC BIOLOGY
- minimal biology
- Biodesign
- Vaccine
- advanced computing
Fingerprint
Dive into the research topics of 'Synthetic self-assembling ADDomer platform for highly efficient vaccination by genetically encoded multiepitope display'. Together they form a unique fingerprint.Projects
- 2 Finished
-
Membrane protein insertion and quality control by the bacterial holo-translocon and FtsH chaperone/protease complex
Berger-Schaffitzel, C. H. (Principal Investigator)
9/01/17 → 8/07/20
Project: Research
-
BrisSynBio: Bristol Centre for Synthetic Biology
Woolfson, D. N. (Principal Investigator)
31/07/14 → 31/03/22
Project: Research